Brain-stimulation therapy at home reduces major depression symptoms

This study highlights the efficacy of home-based tDCS in treating major depressive disorder, with significant improvements in depressive symptoms and remission.

Biogen bids farewell to Aduhelm after tumultuous journey in Alzheimer’s – Pharmaceutical Technology

Share this article Aduhelm garnered a polarised response when the US Food and Drug Administration (FDA) speedily approved it for the treatment of Alzheimer’s disease

January 31, 2024

McConnell Speculation; Army Doc Charged; Ice Cream Recall Over Listeria Concerns

Note that some links may require registration or subscription. Also note that Morning Break will be taking a break on Monday in observance of Labor

September 2, 2023

Mobile phone data may not accurately represent under-resourced or vulnerable populations

Mobile phone data are increasingly used in public health management and disease outbreak response, as demonstrated during the COVID-19 pandemic when location data were used

July 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.